trending Market Intelligence /marketintelligence/en/news-insights/trending/aejjomzeasnggy62aoncjw2 content esgSubNav
In This List

Halyard Health renames to Avanos Medical

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Halyard Health renames to Avanos Medical

Halyard Health Inc. is rebranding to Avanos Medical Inc., effective June 30.

The Alpharetta, Ga.-based medical technology company's ticker on the New York Stock Exchange will change to AVNS from HYH, effective July 2.

The name change follows the conclusion of the $710 million sale of Halyard Health's surgical and infection prevention, or S&IP, unit to Owens & Minor Inc.

"Having completed the divestiture of S&IP, Avanos is now a pure-play medical devices company," said CEO Joe Woody.